4.8 Review

Pharmacological treatments in ARDS; a state-of-the-art update

期刊

BMC MEDICINE
卷 11, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/1741-7015-11-166

关键词

Acute lung injury; Acute respiratory distress syndrome

资金

  1. Astrazenica
  2. MRC [G0701690, MC_G1002460] Funding Source: UKRI
  3. Medical Research Council [G0701690, MC_G1002460] Funding Source: researchfish
  4. Public Health Agency [EAT/3724/07, EAT/4210/09] Funding Source: researchfish

向作者/读者索取更多资源

Despite its high incidence and devastating outcomes, acute respiratory distress syndrome ( ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigated with limited success to date. In this review article we provide a state-of-the-art update on recent and ongoing trials, as well as reviewing promising future pharmacological therapies in ARDS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据